Foundation Fighting Blindness, Inc., Director at Opus Genetics, Inc. (IRD), sold 556,000 shares at $4.96 ($2.8M) on 2026-09-30, disclosed to the SEC on 2026-10-02.
Open-market sale of $2.8M IRD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.